Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The group usually releases upbeat results with huge surprise rates.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 85.21 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 116.16.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • Low profitability weakens the company.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Sector Bio Diagnostics & Testing
1st jan.Capitalisation (M$)Investor Rating
GUARDANT HEALTH, INC.44.55%11 292
EXACT SCIENCES CORPORATION24.60%18 325
INVITAE CORPORATION197.58%8 482
BGI GENOMICS CO., LTD.93.77%7 923
-
ADAPTIVE BIOTECHNOLOGIES CO..55.08%6 329
IOVANCE BIOTHERAPEUTICS, IN..31.68%5 347
-
SEEGENE INC--.--%4 908
CAREDX, INC183.63%3 014
VERACYTE, INC.84.24%2 978
Q-LINEA AB (PUBL)176.52%499
BIOVICA INTERNATIONAL AB (P..243.22%140
EPIGENOMICS AG-68.50%24
More Results
Financials (USD)
Sales 2020 285 M - -
Net income 2020 -202 M - -
Net cash 2020 1 305 M - -
P/E ratio 2020 -55,6x
Yield 2020 -
Capitalization 11 408 M 11 408 M -
EV / Sales 2020 35,5x
EV / Sales 2021 27,3x
Nbr of Employees 622
Free-Float 92,3%
Upcoming event on GUARDANT HEALTH, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes